{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:26Z","timestamp":1791257966971,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,30]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The MYD88 locus is altered in 91% of patients with WM. MYD88 might be new target for therapeutic in WM.<\/jats:p>","DOI":"10.1182\/blood-2012-06-436329","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T04:11:23Z","timestamp":1364357483000},"page":"4504-4511","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":210,"title":["MYD88 L265P mutation in Waldenstrom macroglobulinemia"],"prefix":"10.1182","volume":"121","author":[{"given":"St\u00e9phanie","family":"Poulain","sequence":"first","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"},{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Roumier","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Decambron","sequence":"additional","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Renneville","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Herbaux","sequence":"additional","affiliation":[{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"},{"name":"Service des Maladies du Sang, H\u00f4pital Huriez, Centre Hospitalier R\u00e9gional Universitaire, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bertrand","sequence":"additional","affiliation":[{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tricot","sequence":"additional","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Daudignon","sequence":"additional","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Gali\u00e8gue-Zouitina","sequence":"additional","affiliation":[{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Soenen","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Theisen","sequence":"additional","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Grardel","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Nibourel","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Roche-Lestienne","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"},{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Quesnel","sequence":"additional","affiliation":[{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"},{"name":"Service des Maladies du Sang, H\u00f4pital Huriez, Centre Hospitalier R\u00e9gional Universitaire, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Duthilleul","sequence":"additional","affiliation":[{"name":"Department of Hematology-Immunology-Cytogenetic, Centre Hospitalier, Valenciennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier R\u00e9gional Universitaire, Lille, France;"},{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[{"name":"INSERM U837, Team 3, Cancer Research Institute of Lille, Lille, France; and"},{"name":"Service des Maladies du Sang, H\u00f4pital Huriez, Centre Hospitalier R\u00e9gional Universitaire, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111815575901500_B1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/icb.2011.31","article-title":"Oncogenic MYD88 mutation drives Toll pathway to lymphoma.","volume":"89","author":"Jeelall","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"2019111815575901500_B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111815575901500_B3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1189\/jlb.1206746","article-title":"Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.","volume":"82","author":"Loiarro","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"7332","key":"2019111815575901500_B4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma.","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"5","key":"2019111815575901500_B5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.22014","article-title":"Waldenstr\u00f6m macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.","volume":"86","author":"Gertz","year":"2011","journal-title":"Am J Hematol"},{"issue":"12","key":"2019111815575901500_B6","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1182\/blood-2006-11-055012","article-title":"Waldenstr\u00f6m macroglobulinemia.","volume":"109","author":"Vijay","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2019111815575901500_B7","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1182\/blood-2007-09-115170","article-title":"Targeting NF-kappaB in Waldenstrom macroglobulinemia.","volume":"111","author":"Leleu","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111815575901500_B8","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","article-title":"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom\u2019s macroglobulinemia.","volume":"69","author":"Braggio","year":"2009","journal-title":"Cancer Res"},{"issue":"9","key":"2019111815575901500_B9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111815575901500_B10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia.","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"9","key":"2019111815575901500_B11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3324\/haematol.2012.068478","article-title":"Molecular pathogenesis of Waldenstrom\u2019s macroglobulinemia.","volume":"97","author":"Braggio","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"2019111815575901500_B12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.exphem.2007.05.022","article-title":"Establishment of BCWM.1 cell line for Waldenstr\u00f6m\u2019s macroglobulinemia with productive in vivo engraftment in SCID-hu mice.","volume":"35","author":"Ditzel Santos","year":"2007","journal-title":"Exp Hematol"},{"issue":"19","key":"2019111815575901500_B13","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1182\/blood-2010-12-326868","article-title":"Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.","volume":"117","author":"Hodge","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111815575901500_B14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3324\/haematol.2011.054080","article-title":"BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"2019111815575901500_B15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis.","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"2019111815575901500_B16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0076-6879(06)11009-5","article-title":"TM4 microarray software suite.","volume":"411","author":"Saeed","year":"2006","journal-title":"Methods Enzymol"},{"issue":"20","key":"2019111815575901500_B17","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2009-09-243402","article-title":"Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia.","volume":"115","author":"Roccaro","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111815575901500_B18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111815575901500_B19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3324\/haematol.2009.017251","article-title":"Pathophysiology of Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"95","author":"Stone","year":"2010","journal-title":"Haematologica"},{"issue":"8","key":"2019111815575901500_B20","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2006-02-005488","article-title":"Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.","volume":"108","author":"Chng","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2019111815575901500_B21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.leu.2404520","article-title":"Gene expression profiling of B lymphocytes and plasma cells from Waldenstr\u00f6m\u2019s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.","volume":"21","author":"Guti\u00e9rrez","year":"2007","journal-title":"Leukemia"},{"issue":"21","key":"2019111815575901500_B22","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.434.434","article-title":"Whole-genome sequencing results from 30 patients with Waldenstrom\u2019s macroglobulinemia [abstract].","volume":"118","author":"Hunter","year":"2011","journal-title":"Blood"},{"key":"2019111815575901500_B23","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.","author":"Xu","journal-title":"Blood"},{"issue":"7354","key":"2019111815575901500_B24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"7","key":"2019111815575901500_B25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2012.28","article-title":"Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.","volume":"26","author":"van Maldegem","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"2019111815575901500_B26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas.","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2019111815575901500_B27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3816\/CLML.2011.n.020","article-title":"Distinctive clinical and histological features of Waldenstr\u00f6m\u2019s macroglobulinemia and splenic marginal zone lymphoma.","volume":"11","author":"Arcaini","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2019111815575901500_B28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CLM.2005.n.007","article-title":"Immunophenotypic and cytogenetic comparison of Waldenstrom\u2019s macroglobulinemia with splenic marginal zone lymphoma.","volume":"5","author":"Ocio","year":"2005","journal-title":"Clin Lymphoma"},{"issue":"12","key":"2019111815575901500_B29","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1182\/blood-2007-04-084525","article-title":"CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.","volume":"112","author":"Ho","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111815575901500_B30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrc2541","article-title":"Toll-like receptors and cancer.","volume":"9","author":"Rakoff-Nahoum","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"2019111815575901500_B31","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2009-11-203182","article-title":"SNP array analysis in hematologic malignancies: avoiding false discoveries.","volume":"115","author":"Heinrichs","year":"2010","journal-title":"Blood"},{"issue":"14","key":"2019111815575901500_B32","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2009-10-201848","article-title":"Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.","volume":"115","author":"O\u2019Keefe","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4504\/1366341\/4504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4504\/1366341\/4504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T20:58:16Z","timestamp":1574110696000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/22\/4504\/31370\/MYD88-L265P-mutation-in-Waldenstrom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2013,5,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-436329","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}